Webinars

ERN GENTURIS Webinars

Target audience for the webinars are clinicians, genetic counsellors, clinical scientists and other genetics health professionals. The presentation itself lasts approximately 20-30 minutes, and viewers have the opportunity to send questions on the subject area which will be addressed in a question & answer session afterwards.

Register for the upcoming webinar:

Date

Time

Speaker

Title

Register*

30-09-2020

16:00-17:00

Elke Holinski

HNPCC related tumour risk syndromes  – pathomechanisms and clinical implications

registration link

* Please pay attention to the technical requirements provided with the access link. In case of access problems related to hospital firewalls, please use your private PC and WiFi connection.

View previous webinars:

Date

Time

Speaker

Title

View**

15-04-2020

16.00-17.00

Maurizio Genuardi

The heritability of cancer

 view

20-05-2020

16:00-17:00

Marc Tischkowitz

Hereditary Breast and Ovarian Cancer -
BRCA1, BRCA2 and the basics

 view

17-06-2020

16:00-17:00

Marjolijn Ligtenberg

The Genetic Basis of Cancer

 view

* Recording of the webinar will be made available within a week after the broadcast. Please pay attention to the technical requirements provided with the access link. In case of access problems related to hospital firewalls, please use your private PC and WiFi connection.

Foreseen webinar topics:

  • Polyposis syndromes  (Stefan Aretz, Bonn)
  • Neurocutaneous tumour syndromes (Gareth Evans, Manchester)
  • Hereditary Gastric Cancer (Carla Oliveira, Porto)
  • Li-Fraumeni syndrome (Thierry Frebourg, Rouen)
  • PTEN hamartoma tumour syndrome (Nicoline Hoogerbrugge, Nijmegen)
  • Von Hippel-Lindau Syndrome (Eamonn Maher, Cambridge)
  • Pheochomocytoma / paraganglioma (Evelin Schröck, Dresden)
  • Germline mutations as a therapeutic target in breast cancer (Judith Balmaña, Barcelona)
  • Patients’ personal experience (Tanya Bisseling, Nijmegen)
  • Somatic Mosaicism in Tumour Genetics (Stefan Aretz, Bonn)
  • Variants identified in tumors can be germline – when to refer for germline testing (Kathleen Claes, Ghent)
  • Psycho-oncologic aspects of genturis (Svetlana Lagercrantz, Stockholm)
  • Disease-specific prophylactic surgery (Svetlana Lagercrantz, Stockholm)
  • Genetic counselling (Ignacio Blanco, Barcelona)
  • Methodology and epidemiology (Janet Vos, Nijmegen)
  • Cancer genetics concepts, e.g. penetrance (Thierry Frebourg, Rouen)
  • Diet modificators in prevention and treatment of hereditary cancers (Jan Lubinski, Szczecin)
  • CMMRD syndrome (Chrystelle Colas, Paris)
  • ERN GENTURIS (Nicoline Hoogerbrugge, Nijmegen)